Formulation: A solid
Formal Name: 2-[[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonic acid, monosodium salt
Purity: ≥99% deuterated forms (d1-d4)
Formula Markup: C26H40D4NO6S • Na
Formula Weight: 525,7
Shelf life (days): 730
CAS Number: 2410279-85-3
Notes: Taurochenodeoxycholic acid-d4 is intended for use as an internal standard for the quantification of taurochenodeoxycholic acid (TCDCA; Item No. 20275) by GC- or LC-MS. TCDCA is a taurine-conjugated form of the primary bile acid chenodeoxycholic acid (CDCA; Item No. 10011286).{33901} Serum levels of TCDCA increase approximately 5-fold within two hours and begin to decrease within four hours during an oral lipid tolerance test in humans.{33902} Serum levels of TCDCA are increased in patients with liver cirrhosis and may serve as a marker of disease progression.{33903}